We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USB:NYSEU.S. Bancorp analysis

Data as of Sep 20, 2026 - not real-time

Latest price
$60.06
Risk: low
3/10Low risk

Summary

U.S. Bancorp is priced at $60.06, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 5.9%. RSI sits at 36.4, which reads as approaching oversold, and MACD momentum is bearish. Recent trading has carved out support near $58.81 and resistance around $63.71.
Multiples put this in undervalued territory: 12.0 times earnings against the sector's 15.8. Analyst price targets sit 17.1% above the current price. Revenue is growing at 10.4% on a 29.9% profit margin. The 3.60% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 20.1%, a beta of 0.70 and a maximum drawdown of 16.2%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top market events

  • Chris Lange Sep 2, 2026 0 New Africa / Shutterstock.
  • Looking back on diversified banks stocks’ Q2 earnings, we examine this quarter’s best and worst performers,...
  • US Bancorp stock is holding in the mid-$60s range after its latest earnings update, with investors f

Market outlook

Short term

< 1 year

Neutral

Model confidence4/104 out of 10

Key factors

  • Trading above the 200-day average of 57.34
  • MACD momentum is negative
  • 30-day price change of -5.9%

Medium term

1–3 years

Positive

Model confidence5/105 out of 10

Key factors

  • P/E of 12.0 versus sector average of 15.8
  • Trading above the 200-day average of 57.34
  • Analyst targets imply +17.1% versus the current price

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 12.0 versus sector average of 15.8
  • Analyst targets imply +17.1% versus the current price
  • Profit margin of 29.9% is healthy

Key metrics

Financial health

Revenue Growth10.40%
Profit Margin29.90%
P/E Ratio12.0
ROE12.62%
ROA1.16%
P/B Ratio1.5
Op. Cash Flow$12.5B
Industry P/E15.8

Technical analysis

TrendNeutral
RSI36.4
Support$58.81
Resistance$63.71
MA 20$62.09
MA 50$63.05
MA 200$57.34
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Fair Value$88.84
Target Price$70.33
Upside/Downside17.11%
GradeUndervalued
TypeValue
Dividend Yield3.60%

Risk assessment

Beta0.70
Volatility20.06%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.